ACADIA Pharmaceuticals Inc. - Common Stock (NQ:ACAD)

Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...

Topics Lawsuit

Earnings Scheduled For May 5, 2021 ↗

May 05, 2021

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

NUPLAZID® (pimavanserin) Efficacy Data from Open-Label Extension (OLE) Study Published in Parkinsonism and Related Disorders

June 03, 2021

INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 03, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Topics Lawsuit

June 02, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Topics Lawsuit

June 01, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Topics Lawsuit

May 31, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Topics Lawsuit

May 28, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Topics Lawsuit

May 27, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Topics Lawsuit

Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

May 26, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

May 12, 2021

Stocks finished mostly lower, with the S&P 500 up just 7 bps, while the Qs fell by almost 35 bps. The index had been higher nearly all day and fell sharply going into the final hour of trading.

Topics Lawsuit

Stocks Drop On May 5 As Inflation Rises And Growth Slows ↗

May 05, 2021

Via Talk Markets

Topics Stocks

Acadia Pharmaceuticals Reports First Quarter 2021 Financial Results

May 05, 2021

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

NASDAQ:ACAD Investor Notice: Lawsuit Alleges Misleading Statements by ACADIA Pharmaceuticals Inc ↗

May 04, 2021

San Diego, CA -- (SBWIRE) -- 05/04/2021 -- An investor, who purchased NASDAQ:ACAD shares, filed a lawsuit against ACADIA Pharmaceuticals Inc over alleged Securities Laws violations.

Via SBWire

Topics Lawsuit

Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

May 04, 2021

SHAREHOLDER ALERT: Law Offices of Timothy L. Miles Is Investigating Acadia Pharmaceuticals Inc. on Behalf of Investors

May 02, 2021

SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles Is Investigating Acadia Pharmaceuticals Inc. (ACAD) on Behalf of Shareholders

Via EIN Presswire

Topics Lawsuit

Cramer Gives His Opinion On Lemonade, Pinterest And More ↗

May 02, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he still likes Lemonade Inc (NYSE: LMND). Investors will have to wait a long time for the value of the stock...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates ↗

May 01, 2021

Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...

Via Benzinga

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Pharmaceuticals Inc. (ACAD)

April 30, 2021

From Glancy Prongay & Murray LLP

ACAD Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds ACADIA Pharmaceuticals Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm

April 29, 2021

From Bronstein, Gewirtz & Grossman, LLC

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

April 28, 2021

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Pharmaceuticals Inc. (ACAD)

Topics Lawsuit

April 28, 2021

From Law Offices of Howard G. Smith

EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Acadia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline – ACAD

April 27, 2021

From Rosen Law Firm

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Acadia Pharmaceuticals Inc. (ACAD) Investors

April 27, 2021

From The Law Offices of Frank R. Cruz

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Acadia Pharmaceuticals Inc. (ACAD) Investors

April 26, 2021

From Glancy Prongay & Murray LLP

Shareholder Alert: Robbins LLP Is Investigating Acadia Pharmaceuticals Inc. (ACAD) on Behalf of Shareholders

April 23, 2021

From Robbins LLP